General Information of the Molecule (ID: Mol04214)
Name
Phosphorylated extracellular signal-regulated kinases 1/2 (p-ERK1/2) ,Homo sapiens
Synonyms
Phosphorylated extracellular signal-regulated kinases 1/2 (p-ERK1/2)
    Click to Show/Hide
Molecule Type
Protein
        Click to Show/Hide the Complete Species Lineage
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Type(s) of Resistant Mechanism of This Molecule
  UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Drug
Investigative Drug(s)
1 drug(s) in total
Click to Show/Hide the Full List of Drugs
Astragaloside IV
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
  Unusual Activation of Pro-survival Pathway (UAPP) Click to Show/Hide
Disease Class: Lung adenocarcinoma [ICD-11: 2C25.0] [1]
Resistant Disease Lung adenocarcinoma [ICD-11: 2C25.0]
Resistant Drug Astragaloside IV
Molecule Alteration Expression
Down-regulation
Experimental Note Revealed Based on the Cell Line Data
Cell Pathway Regulation EREG/ErbB/ERK signalling pathway Regulation N.A.
In Vitro Model A549/TR cells Epithelium Homo sapiens (Human) CVCL_C5S0
Experiment for
Molecule Alteration
Western blot assay
Experiment for
Drug Resistance
Sphere-forming assay; CCK8 assay
Mechanism Description ASIV reversed taxol resistance through suppression of the stemness-associated genes of spheres in NSCLC. The mechanism exploration revealed that ASIV promoted the K48-linked polyubiquitination of EREG along with degradation. Moreover, EREG could be triggered by chemo-drug treatment. Consequently, EREG bound to the ErbB receptor and activated the ERK signal to regulate the expression of the stemness-associated genes. Inhibition of EREG/ErbB/ERK could reverse the taxol-resistance by inhibiting the stemness-associated genes.
References
Ref 1 Inhibition of EREG/ErbB/ERK by Astragaloside IV reversed taxol-resistance of non-small cell lung cancer through attenuation of stemness via TGFbeta and Hedgehog signal pathway. Cell Oncol (Dordr). 2024 Dec;47(6):2201-2215.

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.